Skip to main content

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ALGS holding history

Aligos Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALGS overviewAll 13F holders of ALGSFull Q2 2026 holdings

Shares (Q2 2026)
10,800
Value
$62.3K
% of portfolio
<0.1%
Quarters held
20
Since Q3 2021
Holdings of ALGS by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,800$62.3K<0.1%−89,650−89.2%ReducedHolders
Q1 2026100,450$746.3K<0.1%+15,006+17.6%AddedHolders
Q4 202585,444$796.3K<0.1%+30,425+55.3%AddedHolders
Q3 202555,019$539.2K<0.1%+2,475+4.7%AddedHolders
Q2 202552,544$378.8K<0.1%+12,968+32.8%AddedHolders
Q1 202539,576$326.5K<0.1%+28,133+245.9%AddedHolders
Q4 202411,443$455.9K<0.1%−2,000−14.9%ReducedHolders
Q3 202413,443$116.4K<0.1%−17,311−56.3%ReducedConverted for a 1-for-25 splitHolders
Q2 2024768,839$269.1K<0.1%−39,421−4.9%ReducedHolders
Q1 2024808,260$792.0K<0.1%+318,300+65.0%AddedHolders
Q4 2023489,960$325.0K<0.1%+168,600+52.5%AddedHolders
Q3 2023321,360$240.0K<0.1%−109,195−25.4%ReducedHolders
Q2 2023430,555$418.0K<0.1%−22,305−4.9%ReducedHolders
Q1 2023452,860$396.0K<0.1%−79,400−14.9%ReducedHolders
Q4 2022532,260$507.0K<0.1%−198,338−27.1%ReducedHolders
Q3 2022730,598$804.0K<0.1%−172,502−19.1%ReducedHolders
Q2 2022903,100$1.09M<0.1%+540,786+149.3%AddedHolders
Q1 2022362,314$779.0K<0.1%+307,814+564.8%AddedHolders
Q4 202154,500$647.0K<0.1%+1,300+2.4%AddedHolders
Q3 202153,200$825.0K<0.1%+53,200NewHolders